Marie Stoner, scientific director of bio-medical company Clinical Cell Culture (C3), has grown her once hospital laboratory into an extremely profitable operation which could soon float on the stock exchange.

Marie Stoner, scientific director of bio-medical company Clinical Cell Culture (C3), has grown her once hospital laboratory into an extremely profitable operation which could soon float on the stock exchange.